The 3D Ready™ Organoid Expansion Service provides researchers with up to ten million high-quality, low-variability and ready-to-use organoids, from their own organoid lines.
Molecular Devices understands the challenges of conventional manual organoid cultivation, which often yields limited quantities of inconsistent, non-reproducible organoids.
Molecular Devices’ specialized knowledge and patent-pending bioprocess technologies revolutionize the field by enabling the production of millions of consistent organoids in each batch.
With the 3D Ready Organoid Expansion Services, users can now obtain more statistically significant and dependable data from repeated assays or high-throughput screenings.
Custom Organoid Expansion: Scale Up the Research with Confidence
This distinctive, tailored organoid expansion service lets users scale their organoid lines to meet specific research needs. Users can now conduct large-scale screenings using millions of organoids, enabling robust statistical analysis.
This commitment to consistent, reproducible organoid batches ensures precise outcomes, enabling users to confidently screen thousands of compounds while upholding the integrity of their research.
Reproducible Organoids: Unrivaled Quality and Standardization
The distinctive, tailored organoid expansion service lets users enhance their organoid lines to meet specific research requirements. Users can now conduct large-scale screenings using millions of organoids, enabling robust statistical analysis.
This commitment to consistent, reproducible organoid batches ensures precise outcomes, enabling users to confidently screen thousands of compounds while maintaining research integrity.
Assay-Ready Organoids: Streamlined Workflow, Accelerated Research
Eliminate the challenges associated with organoid growth by utilizing assay-ready organoids sourced from the user’s own organoid lines. These convenient consumables can be effortlessly stored in the laboratory freezer until required.
By reducing the labor-intensive task of organoid culture, users can boost laboratory productivity and spend more time on their research. This technology optimizes workflow, enabling users to focus on scientific research and accelerate discoveries.
Discover how our Organoid Expansion Service can help you obtain more patient-relevant results during drug development. Video Credit: Molecular Devices UK Ltd
Features
- Assay-Ready Convenience
- The organoids are stored in frozen vials, making them ready for immediate use whenever needed.
- Scalable Production
- The method can produce more than 10 million reproducible organoids, enabling high-throughput, repeatable experiments and supporting efficient, dependable research.
- Reproducible Models
- By minimizing variability and ensuring consistent results across batches, organoids improve data quality, enabling users to obtain dependable, reproducible research outcomes.
- Outsourced Expertise
- Conserve time and financial resources by delegating organoid production to a skilled team that delivers superior products, allowing in-house resources to focus on more critical tasks.
- Stringent Quality Control
- The comprehensive, customizable quality control procedure ensures organoids consistently meet the highest standards, delivering precise, dependable research data.
- Customized Solutions
- Tailored expansion projects, designed to meet specific needs, allow users to enhance their own organoid lines while preserving the integrity of their distinct research objectives.
From Vision to Reality: A Tailored Organoid Expansion Experience
Molecular Devices collaborates closely with users to fully understand their specific requirements. Their goal is to help users develop their own organoid lines, customized to their specific needs and objectives.
They have a strong track record of supporting pharmaceutical companies, biotechnology firms, and academic institutions in expanding their organoid lines. Their expertise centers on providing high-quality, standardized organoids that meet the stringent demands of the life sciences sector.
Image Credit: Molecular Devices UK Ltd
- Project Scoping: Experts engage in comprehensive dialogues with users to understand the project’s needs, including aspects like suitability, scalability, quality assurance, and timelines. Molecular Devices tailors the approach to meet specific requirements.
- Pre-Expansion: Molecular Devices establishes the parameters for the organoid line within the bioreactor, ensuring optimal growth conditions.
- Bioreactor-Based Expansion: Molecular Devices enhances organoid growth through a specialized bioreactor system. The harvested organoids are carefully counted, measured, and cryopreserved in vials for future applications.
- Quality Control Testing: Thawed vials undergo rigorous quality control assessments. This includes evaluating post-thaw recovery, microbial testing, and tailored quality control methods such as medication validation and STR analysis.
- Reproducible Batches: Each batch may contain over 10 million organoids, which are prepared for thawing, plating, and testing as required. This ensures a consistent, reliable supply of organoids for research activities.